MCMY416

MCMY416 is an orally active and blood brain barrier (BBB) permeability apicomplexan phenylalanine tRNA synthetase inhibitor, and shows antiparasitic activity [1].

Product Specifications

UNSPSC

12352005

Target

Aminoacyl-tRNA Synthetase; Parasite

Type

Reference compound

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/mcmy416.html

Smiles

[H][C@]1([C@@H](C2=CC=C(C#CC3=CCCCC3)C=C2)CC4)N4CCCN(C(NC5=CC=C(OC)C=C5)=O)C1

Molecular Formula

C30H35N3O2

Molecular Weight

469.62

References & Citations

[1]Ence CC, et al. Bicyclic pyrrolidine inhibitors of Toxoplasma gondii phenylalanine t-RNA synthetase with antiparasitic potency in vitro and brain exposure. Preprint. bioRxiv. 2024;2024.02.28.582607. Published 2024 Feb 28. |[2]Ence CC, et al. Bicyclic pyrrolidine inhibitors of Toxoplasma gondii phenylalanine t-RNA synthetase with antiparasitic potency in vitro and brain exposure. Preprint. bioRxiv. 2024;2024.02.28.582607. Published 2024 Feb 28.